Published: May 7th 2024 | Updated: May 21st 2024
FDA accepts BLA for subcutaneous nivolumab in solid tumors
Published: July 29th 2024 | Updated: October 29th 2024
Study highlights need for improved enrollment, reporting in urolithiasis trials
Published: July 10th 2024 | Updated: October 29th 2024
AUA, GURS, SUFU amend guideline for incontinence after prostate treatment
Published: August 6th 2024 | Updated: October 29th 2024
Investigators link genomic and clinical data to real-world outcomes in prostate cancer
Published: August 22nd 2024 | Updated: October 29th 2024
Olaparib monotherapy shows benefit in HRR+ biochemically recurrent prostate cancer
Published: August 8th 2024 | Updated: October 29th 2024
Stockholm3 shows benefit in detecting prostate cancer across ethnicities